Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Villanueva V, Bermejo P, Montoya J, Massot-Tarrús A, Galiano ML, Toledo M, Rodriguez-Uranga JJ, Bertol V, Mauri JÁ, Poza JJ, Bonet M, Castro-Vilanova MD, Ruiz-Giménez J, López-González FJ, Rodríguez-Osorio X, Tortosa-Conesa D, Ojeda J, Giner P, Garcés M, Alvarez BM, Quiroga-Subirana P, Esteve P, Baiges JJ, Hampel K. Villanueva V, et al. Among authors: mauri ja. Epilepsy Behav. 2019 Aug;97:51-59. doi: 10.1016/j.yebeh.2019.05.003. Epub 2019 Jun 7. Epilepsy Behav. 2019. PMID: 31181429
Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
Villanueva V, López FJ, Serratosa JM, González-Giraldez B, Campos D, Molins A, Rodriguez Uranga J, Mauri JA, Salas-Puig J, Toledo M, Sánchez-Alvarez JC, Moreno A, Serrano-Castro PJ, Saiz-Diaz RA, González de la Aleja J, de la Peña P, Asensio M. Villanueva V, et al. Among authors: mauri ja. Epilepsy Behav. 2013 Nov;29(2):349-56. doi: 10.1016/j.yebeh.2013.07.024. Epub 2013 Aug 30. Epilepsy Behav. 2013. PMID: 23999191
Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
Garcés M, Villanueva V, Mauri JA, Suller A, García C, López González FJ, Rodríguez Osorio X, Fernández Pajarín G, Piera A, Guillamón E, Santafé C, Castillo A, Giner P, Torres N, Escalza I, Del Villar A, García de Casasola MC, Bonet M, Noé E, Olmedilla N. Garcés M, et al. Among authors: mauri ja. Epilepsy Behav. 2014 Jul;36:144-52. doi: 10.1016/j.yebeh.2014.05.015. Epub 2014 Jun 10. Epilepsy Behav. 2014. PMID: 24922617
NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
Villanueva V, Saiz-Diaz R, Toledo M, Piera A, Mauri JA, Rodriguez-Uranga JJ, López-González FJ, Gómez-Ibáñez A, Garcés M, González de la Aleja J, Rodríguez-Osorio X, Palao-Duarte S, Castillo A, Bonet M, Ruiz-Giménez J, Palau J, Arcediano A, Toledo M, Gago A. Villanueva V, et al. Among authors: mauri ja. Epilepsy Behav. 2016 Dec;65:25-32. doi: 10.1016/j.yebeh.2016.09.033. Epub 2016 Nov 16. Epilepsy Behav. 2016. PMID: 27863278
Levels of anger in epilepsy patients treated with eslicarbazepine acetate.
Toledo M, Mazuela G, Mauri JA, Rodriguez-Osorio X, Gómez-Eguilaz M, Castro-Vilanova D, Rodriguez-Uranga J, Santamarina E. Toledo M, et al. Among authors: mauri ja. Acta Neurol Scand. 2019 Jul;140(1):48-55. doi: 10.1111/ane.13099. Epub 2019 May 9. Acta Neurol Scand. 2019. PMID: 30953593
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study.
Villanueva V, Serratosa JM, Guillamón E, Garcés M, Giráldez BG, Toledo M, Salas-Puig J, López González FJ, Flores J, Rodríguez-Uranga J, Castillo A, Mauri JA, Camacho JL, López-Gomáriz E, Giner P, Torres N, Palau J, Molins A. Villanueva V, et al. Among authors: mauri ja. Epilepsy Res. 2014 Sep;108(7):1243-52. doi: 10.1016/j.eplepsyres.2014.04.014. Epub 2014 May 14. Epilepsy Res. 2014. PMID: 24908564
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study.
Villanueva V, Garcés M, López-González FJ, Rodriguez-Osorio X, Toledo M, Salas-Puig J, González-Cuevas M, Campos D, Serratosa JM, González-Giráldez B, Mauri JA, Camacho JL, Suller A, Carreño M, Gómez JB, Montoya J, Rodríguez-Uranga J, Saiz-Diaz R, González-de la Aleja J, Castillo A, López-Trigo J, Poza JJ, Flores J, Querol R, Ojeda J, Giner P, Molins A, Esteve P, Baiges JJ. Villanueva V, et al. Among authors: mauri ja. Epilepsy Res. 2016 Oct;126:201-10. doi: 10.1016/j.eplepsyres.2016.08.001. Epub 2016 Aug 4. Epilepsy Res. 2016. PMID: 27521586
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.
Villanueva V, Bermejo P, Montoya J, Toledo M, Gómez-Ibáñez A, Garcés M, Vilella L, López-González FJ, Rodriguez-Osorio X, Campos D, Martínez P, Giner P, Zurita J, Rodríguez-Uranga J, Ojeda J, Mauri JA, Camacho JL, Ruiz-Giménez J, Poza JJ, Massot-Tarrús A, Galiano ML, Bonet M. Villanueva V, et al. Among authors: mauri ja. Acta Neurol Scand. 2017 Sep;136(3):254-264. doi: 10.1111/ane.12720. Epub 2016 Dec 9. Acta Neurol Scand. 2017. PMID: 27935017
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series.
Gómez-Ibáñez A, Serratosa JM, Guillamón E, Garcés M, Giráldez BG, Toledo M, Salas-Puig J, López-González FJ, Rodríguez-Uranga J, Castillo A, Mauri JA, Camacho JL, López-Gomáriz E, Giner P, Torres N, Palau J, Molins A, Villanueva V. Gómez-Ibáñez A, et al. Among authors: mauri ja. Seizure. 2017 May;48:53-56. doi: 10.1016/j.seizure.2017.04.003. Epub 2017 Apr 7. Seizure. 2017. PMID: 28419947 Free article.
45 results